Our results broaden the prognostic value of ABCA1, ACSL1, AGPAT1 and SCD genes in all stages of CRC, leading to future precision medicine approaches and “omics”-guided therapies. The gene discussed is AGPAT1; the disease is colorectal carcinoma.